Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology.
about
Influenza A Virus Infection, Innate Immunity, and ChildhoodModulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory DrugsEvaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.Pregnancy outcome and clinical status of gilts following experimental infection by H1N2, H3N2 and H1N1pdm09 influenza A viruses during the last month of gestation.Differential Immune Profiles in Two Pandemic Influenza A(H1N1)pdm09 Virus Waves at Pandemic Epicenter.Translational research on influenza virus infection using a nonhuman primate model.The influence of experimental infection of gilts with swine H1N2 influenza A virus during the second month of gestation on the course of pregnancy, reproduction parameters and clinical statusInnate immunity to influenza virus infection.Immune and inflammatory response in pigs during acute influenza caused by H1N1 swine influenza virus.L-selectin Is Essential for Delivery of Activated CD8(+) T Cells to Virus-Infected Organs for Protective ImmunityType I interferons regulate susceptibility to inflammation-induced preterm birth.Kinetics of pulmonary immune cells, antibody responses and their correlations with the viral clearance of influenza A fatal infection in mice.New fronts emerge in the influenza cytokine storm.The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis.Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts.Direct IL-6 Signals Maximize Protective Secondary CD4 T Cell Responses against Influenza.TLR ligand induced IL-6 counter-regulates the anti-viral CD8(+) T cell response during an acute retrovirus infection.Nasal priming with immunobiotic Lactobacillus rhamnosus modulates inflammation-coagulation interactions and reduces influenza virus-associated pulmonary damage.Thimerosal compromises human dendritic cell maturation, IL-12 production, chemokine release, and T-helper polarization.Early IL-6 signalling promotes IL-27 dependent maturation of regulatory T cells in the lungs and resolution of viral immunopathology.Miniaturized bronchoscopy enables unilateral investigation, application, and sampling in mice.Pulmonary transcriptomic responses indicate a dual role of inflammation in pneumonia development and viral clearance during 2009 pandemic influenza infection.Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates.Protective Effects of Neural Crest-Derived Stem Cell-Conditioned Media against Ischemia-Reperfusion-Induced Lung Injury in Rats.Enrofloxacin in therapeutic doses alters cytokine production by porcine PBMCs induced by lipopolysaccharide.Protective effect of naringenin against lipopolysaccharide-induced injury in normal human bronchial epithelium via suppression of MAPK signaling.Induction of influenza-specific local CD8 T-cells in the respiratory tract after aerosol delivery of vaccine antigen or virus in the Babraham inbred pig.Alternaria alternata challenge at the nasal mucosa results in eosinophilic inflammation and increased susceptibility to influenza virus infection.Control of Listeria monocytogenes infection requires classical IL-6 signaling in myeloid cells
P2860
Q26799729-4F587B17-D8DB-4CD8-86EF-9EC987F00753Q26800158-49427F53-A076-4556-B767-032196FC49A6Q30362700-EEBAE09A-BFA6-4D86-BF0A-0225406429F8Q30376554-A57638A8-95DB-4BD3-8B62-0B80E93236D9Q30382796-D1A1F340-4DC8-4B47-84AF-6083D5E3AA38Q30383873-B283A1C2-A44C-409D-B3BB-0E4A9B402F23Q33794841-4849C268-1B4E-4D30-B1AA-00F8968CD642Q33923354-BE35C99A-7874-49B4-B343-F3DBADB8549BQ34235413-09434C67-4ACB-4B9D-9602-A0CFED3D483FQ36547842-9C044E6E-0EDD-4903-8B83-94712AE572ECQ37677428-CBD5D676-AA11-4FE5-9F27-74F79B2D0BA9Q37703101-811E2BBB-2538-4990-A0C7-93AE027C1507Q38400762-C71BCFDC-8FD1-490D-9B42-2CB0302D6F58Q38940024-D3D0BAF2-BE56-422F-B474-B9B60F4714F0Q40179542-68454B7E-DD22-4053-9E60-2E58F1711454Q40534430-371B0E4D-2E65-4F76-AFEC-1CD81B17FF51Q40931701-E9D4BF98-184E-4ACC-885F-DE19237E8FC0Q41162869-C1A88100-6A49-4550-8A2F-7B762554C1C7Q41648233-18CCAFAF-6621-4B8A-9D50-891F5FD95888Q41929315-C0D6CF56-CA3A-46C2-A715-56F46BE073B4Q42210341-1F8BF55E-4D54-4D46-A863-BF8C455F295DQ42377486-DF75C493-992D-4B2C-8136-C02C5F237D99Q47562002-CF8517E1-A20C-4177-91F0-1856A64957C5Q47878925-E7149B7D-C2B7-4069-90C3-BC540D709904Q51169060-3B9565BF-81D8-4B0B-8F6F-D416964E7C67Q51691655-02E857A1-74CE-413A-BC12-54721D8274A4Q54109159-0789458B-3C27-4ABA-8C26-704303E3196BQ54267867-80CE87B0-863E-4B2A-A138-E4F6ABA620D5Q58782375-05895E20-EA8F-45A0-991C-8A7CB4FE1D12
P2860
Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interleukin-6 limits influenza ...... against fatal lung pathology.
@en
Interleukin-6 limits influenza ...... against fatal lung pathology.
@nl
type
label
Interleukin-6 limits influenza ...... against fatal lung pathology.
@en
Interleukin-6 limits influenza ...... against fatal lung pathology.
@nl
prefLabel
Interleukin-6 limits influenza ...... against fatal lung pathology.
@en
Interleukin-6 limits influenza ...... against fatal lung pathology.
@nl
P2093
P2860
P50
P921
P356
P1476
Interleukin-6 limits influenza ...... against fatal lung pathology.
@en
P2093
Anja Bloom
Anwen S Williams
Beatrice Ondondo
James P Hindley
Kathryn Smart
Mathew Clement
Sarah N Lauder
P2860
P304
P356
10.1002/EJI.201243018
P407
P577
2013-08-12T00:00:00Z